These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1680596)

  • 1. Psoriasis-like skin reaction in a patient with rheumatoid arthritis after sulphasalazine therapy.
    Bliddal H; Stangerup M
    Clin Rheumatol; 1991 Jun; 10(2):178-80. PubMed ID: 1680596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatal neutropenic enterocolitis associated with sulphasalazine therapy for rheumatoid arthritis.
    Chakravarty K; Scott DG; McCann BG
    Br J Rheumatol; 1992 May; 31(5):351-3. PubMed ID: 1349846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing alveolitis due to sulphasalazine in a patient with rheumatoid arthritis.
    Boyd O; Gibbs AR; Smith AP
    Br J Rheumatol; 1990 Jun; 29(3):222-4. PubMed ID: 1972634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
    Bax DE; Amos RS
    Ann Rheum Dis; 1986 Feb; 45(2):139-40. PubMed ID: 2868699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis.
    Nisar M; Carlisle L; Amos RS
    Br J Rheumatol; 1994 Jul; 33(7):651-4. PubMed ID: 7912633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C; Coughlan R
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The three week sulphasalazine syndrome.
    Brooks H; Taylor HG; Nichol FE
    Clin Rheumatol; 1992 Dec; 11(4):566-8. PubMed ID: 1362531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of acetylator status on sulphasalazine efficacy and toxicity in patients with rheumatoid arthritis.
    Kitas GD; Farr M; Waterhouse L; Bacon PA
    Scand J Rheumatol; 1992; 21(5):220-5. PubMed ID: 1359635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of methotrexate and sulphasalazine vs methotrexate alone: a randomized open clinical trial in rheumatoid arthritis patients resistant to sulphasalazine therapy.
    Haagsma CJ; van Riel PL; de Rooij DJ; Vree TB; Russel FJ; van't Hof MA; van de Putte LB
    Br J Rheumatol; 1994 Nov; 33(11):1049-55. PubMed ID: 7981992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine in rheumatoid arthritis.
    Boey ML; Lee E; Feng PH
    Singapore Med J; 1988 Jun; 29(3):285-8. PubMed ID: 2903555
    [No Abstract]   [Full Text] [Related]  

  • 12. Sulphasalazine-induced systemic lupus erythematosus in a patient with erosive arthritis.
    Walker EM; Carty JE
    Br J Rheumatol; 1994 Feb; 33(2):175-6. PubMed ID: 7909272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphasalazine in rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Lancet; 1985 May; 1(8438):1167. PubMed ID: 2860375
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term usage and side-effect profile of sulphasalazine in rheumatoid arthritis.
    van Riel PL; van Gestel AM; van de Putte LB
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():40-2. PubMed ID: 8535648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrocytosis and sulphasalazine treatment of rheumatoid arthritis.
    Ralston SH; Willocks LJ; Shaw RW; Pitkeathly DA
    Br J Rheumatol; 1987 Dec; 26(6):472-3. PubMed ID: 2891393
    [No Abstract]   [Full Text] [Related]  

  • 16. Ten years of sulphasalazine use in rheumatoid arthritis.
    McConkey B
    Br J Rheumatol; 1989 Apr; 28(2):175-6. PubMed ID: 2565130
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulphasalazine-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Khattak FH; Morris IM; Mattingly PC
    Br J Rheumatol; 1996 Jan; 35(1):104. PubMed ID: 8624617
    [No Abstract]   [Full Text] [Related]  

  • 18. Raised serum alkaline phosphatase and aspartate transaminase levels in two rheumatoid patients treated with sulphasalazine.
    Farr M; Symmons DP; Bacon PA
    Ann Rheum Dis; 1985 Nov; 44(11):798-800. PubMed ID: 2865931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
    Bax DE; Amos RS
    Ann Rheum Dis; 1985 Mar; 44(3):194-8. PubMed ID: 2858182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutropenia in patients with rheumatoid arthritis, treated with sulphasalazine.
    Marouf ES; Morris IM
    Br J Rheumatol; 1990 Oct; 29(5):407-9. PubMed ID: 1977490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.